Carl Whatley leads Vitruvias with expert knowledge of all facets of the generic pharmaceutical drug industry. His leadership background coupled with a passion to expand the generic drug market have led to the development of multiple successful companies bringing next generation drugs into American pharmacies.
Bryce Harvey leads Vitruvias as Vice Manager, Co-Founder and Director. With decades of experience at Johnson & Johnson and successful growth of two companies prior to Vitruvias, Bryce is a seasoned industry leader with an acute sense for business development and key partnerships.
Dr. Roger Graben is responsible for building and operating the commercial and quality assurance operations at Vitruvias. With decades of success in hospital, clinical, retail and academic settings coupled with executive-level business experience, Roger is a key leader who brings excellence and expansion to Vitruvias products and partnerships.
Dr. Kevin Swiss serves Vitruvias as the Vice President of Development. He is committed to building global partnerships with top labs and scientists expanding the American market with inherently difficult to develop generic drugs. Kevin brings a rich regulatory and scientific background accompanied by repeated success achieving new drug approvals.
Lisa Apolis is a certified Regulatory Affairs (RAC) management professional with a strong chemistry background and extensive pharmaceutical experience. Lisa’s hands-on management experience in Regulatory Affairs across both small and large pharma allow her to be a strong leader and contributor in the Regulatory arena.
Eliot Murray joined Vitruvias in January of 2018, after having consulted with the company during its startup phase and Series A capital raise. In his role as Senior Controller, he is responsible for all financial and accounting operations of the company. Eliot brings strong financial acumen to the team by way of unique experiences across diversified industries.
Pam Norris joined Vitruvias in 2017. She was first introduced to the pharmaceutical industry in 2005 where she began work for Midlothian Laboratories in Montgomery, AL. Over the years she has served in diverse roles for various companies within the industry. Her knowledge and experience bring a great addition to the Vitruvias Therapeutics team.
Sara Caldwell is responsible for the procurement, planning, and execution of our current development programs. She brings her unique capacity, business acumen, and superior management skills to each project.
Tripp Whatley joined Vitruvias in 2017 where he serves as a financial and commercial analyst. He is a recent graduate of Auburn University, where he earned a degree in Finance. His introduction to healthcare began with New York-based Torreya Partners, where in 2016 he served as a healthcare analyst.
His competitive, thorough approach to financial analytics is a continuation of a winning attitude that began on the baseball field, and culminated with a national championship ring won during the 2013 Junior College World Series.